The NEOMED Institute is a response to the changing pharma R&D business model. In view of the considerable gap between basic research and the commercialization of new drugs, we seek to create a bridge.
We provide industrial expertise in drug discovery and development combined with funding and a favourable ecosystem to transform innovations into solid therapeutic solutions. We drive drug discovery activities up to the stage of human proof of concept. This stage is an important turning point, where projects become attractive to the biopharmaceutical industry or can constitute the basis for the creation of solid start-up companies.
The NEOMED Institute is jointly funded by the pharmaceutical industry, the Ministère de l’Économie, de la Science et de l’Innovation du Québec, and the Networks of Centres of Excellence (NCE) of Canada.
|For whom ?||Researchers and companies|
|How much ?||Depending on the program|
|What ?||Venture funds|
|For what ?||Projects with a high potential to impact biopharmaceutical research on its ability to address unmet needs|